Patents

Coty Patents Kit Of Sun Products

U.S. Patent No. 7,892,523 B2 Coty B.V., Haarlem, The Netherlands, has been granted a U.S. patent for treating the skin with a kit of sun products.

Prior to intensive exposure to UV radiation, a pre-sun product, which is the first part of the kit, is applied to the skin one to several times a day for 2-7 days. This product is comprised of a radical scavenger, caffeine, a complex with amino acid salts consisting of sorbitol, arginine-HCl, ornithine-HCl, tyrosine and SiO2, an enzyme photolyase enclosed in liposomes and UV endonuclease, and an extract from corallina officinalis with propylene glycol.

During intensive exposure to UV radiation, the second part of the kit is then applied to the skin. It is comprised of UVA and UVB filters and contains at least 3% by weight of UVA filters, relative to the total weight of the sun product, wherein the ratio of UVA and UVB filters is 1:1.8-2.2.

After intensive exposure to UV radiation, an after-sun product (the third part of the kit) is applied to the skin at least once or one to several times for one to seven days. This product is comprised of the same ingredients as the pre-sun product, with the content of the radical scavenger and the enzyme photolyase 50-90% by weight lower, the content of the enzyme UV endonuclease 50-90% by weight higher, compared to the pre-sun product, and the extract is replaced with a cooling plant extract or a plant extract mixture selected from the group consisting of water melon extract and a mixture of water melon extract, rose flower extract and jasmine flower extract. The extracts of watermelon, rose flower and jasmine flower are water/glycerine extracts.



Cosmetic Foundation Patented by P&G
U.S. Patent No. 7,892,570 B2; Procter & Gamble Company has patented a cosmetic composition that is comprised of metal oxide particles having a coating of organo-functionalized silicone fibrils that are bonded to and extend away from the surface of the metal oxide particles, wherein the fibril-coated metal oxide particles are coated with a hydrophobic coating; and a cross-linked, non-emulsifying organopolysiloxane elastomer selected from the group consisting of a dimethicone/vinyl dimethicone crosspolymer, a dimethicone/phenyl vinyl/ dimethicone crosspolymer, a lauryl dimethicone/vinyl dimethicone crosspolymer and mixtures thereof.

Skinvisible Inviscare Issued Canadian Patent The Canadian Patent Office has issued a Notice of Allowance for the comprehensive technology patent for Skinvisible’s Invisicare polymer delivery system. Invisicare is the core technology in Skinvisible’s portfolio of products that consists of 36 formulated topical products including prescription, over-the-counter and cosmetic formulations. Invisicare is said to enhance the delivery of topical products with water insoluble actives as well as certain cationic actives by controlling the release of these actives as well as binding the products to the skin for an extended duration. The Canadian patent for Invisicare (Patent No. 758/10701.492) includes a total of 48 claims and protects in three key areas—“Topical Composition,” “Topical Composition Precursor” and “Methods for Manufacturing and Using.” Internationally, this is the seventh comprehensive patent granted to Skinvisible for its Invisicare technology. The Canadian patent is equivalent to the Invisicare patents already granted in Australia, China, Hong Kong, India, Japan and Korea. Skinvisible also holds four U.S. patents that include one product patent and three patents relating to Invisicare. Currently, Skinvisible has 28 patents pending including 12 in the U.S. and 16 international applications covering six patents, according to the company.

Sunscreen Composite Particles
U.S. Patent No. 7,892,524 B2; Conopco, Inc., Englewood Cliffs, NJ, has patented composite particles comprising an organic sunscreen agent dispersed within a condensation polymerized resin. The composite particles have an average particle size ranging from about 10 to about 2,000nm. The condensation polymerized resin has carboxylic acid groups and the composite particles have a dielectric constant ranging from 6.5-18.



Reckitt Benckiser Patents Glassware Corrosion Inhibitor
U.S. Patent No. 7,893,013 B2; Reckitt Benckiser N.V. has been awarded a U.S. patent for a glassware corrosion inhibitor for use in a dishwasher. It is comprised of a water-soluble zinc containing glass or ceramic composition, partially in the form of a shaped body that is effective to reduce corrosion of glassware, and a surfactant containing composition. The article is held in a container having perforated walls to allow a controlled circulation of wash liquor in and out of the container. The container is comprised of compartments to hold the glass or ceramic composition and the surfactant composition separately.



Encapsulated Bleaching Agent Patented by Henkel
U.S. Patent No. 7,897,556 B2; Henkel has patented an encapsulated bleaching agent particle that consists of a core and a water-coating material that surrounds this core. The core is comprised of phthalimidoperoxyhexanoic acid in particulate form and polyvinyl alcohol. The coating material is comprised of polyvinyl alcohol and a mineral acid, wherein the bleaching agent particle is a solid particle.



Fabric Treatment For Stain Release
U.S. Patent No. 7,893,014 B2; Gregory van Buskirk of Danville, CA has patented a method of treating fabrics in a washing machine to provide fabric protective properties. It entails depositing a first composition onto the fabric in a first treatment liquor. This composition contains a hydrophobic agent characterized as having a melting point or glass transition temperature of less than 100°C; a fluoropolymer; and an effective amount of a zeta potential modifier. The fabric is cured at a temperature above ambient temperature but less than 100°C. A second composition is then deposited onto the fabric in a second treatment liquor. This second composition comprises a hydrophobic agent having a melting point or glass transition temperature of less than 100°C; and an effective amount of a zeta potential modifier; but it does not comprise a fluoropolymer. The fabric is then cured at a temperature above ambient temperature but less than 100°C.

The first fabric protective properties are comprised of increased water repellency; increased oil repellency; soil and stain release; improved feel; improved softness; improved resistance to damage; and any combination thereof. The second fabric protective properties are comprised of at least one of the first fabric protective properties.



Composition for Improving Long-Wear Cosmetics
U.S. Patent No. 7,879,346 B2; STC Nara Co., Ltd., Cheonan, Chungcheongnam-do, Korea, has patented a cosmetic composition that is comprised of an oil phase that contains trimethylsiloxysilicate, volatile oil, and dimethicone/vinyl-dimethicone cross- polymer; powder ingredients that include disteardimonium hectorite, methyl methacrylate crosspolymer, and pulverulent body; and cosmetic additives. The volatile oil is selected from the cyclopentasiloxane, methicone, dimethicone, C8-20 isoparaffin, propylene carbonate, polydecene, liquid paraffin, and a combination thereof, and the pulverulent body is selected from the group consisting of iron oxide, titanium oxide, zinc oxide, talc, silica, nylon powder and a combination thereof. The additives are selected from UV absorbent, a preservative, a perfume and a combination thereof.



J&J Patents Compositions Containing Soy
U.S. Patent No. 7,897,144 B2; Johnson & Johnson Consumer Companies, Inc. has patented a topical composition that contains a soy product having a trypsin inhibitory activity of at least about 15% and a microbial content less than about 1000 cfu per gram; and a cosmetically-acceptable topical carrier.



Kao Patents Highlighter
U.S. Patent No. 7,896,930 B2; KPSS-Kao Professional Salon Services GmbH, Darstadt, Germany, has patented a process for preparing highlight composition and their use.

The method entails mixing at least one powder composition being water-free bleaching powder and/or granules with a liquid composition. The powder composition is added to a liquid composition by passing through a sieve.



External Medicine For Dermatitis
U.S. Patent No. 7,897,161 B2; CAC Corporation of Japan has patented an external medicine for treating atopic dermatitis and psoriasis vulgaris. The medicine is an aqueous solution that contains adrenocortical steroid, cyclodextrin, dextran or pullulan, xyloglucan, trehalose, laminaran, krestin and pectin. The medicine then further comprises at least one selected from the group consisting of grape sugar, mutan, lentinan, sodium chloride and potassium chloride.



Wella Patents Hair Wax
U.S. Patent No. 7,906,107 B2; Wella AG, Darmstadt, Germany, has patented hair wax with a liquid or creamy consistency. The hair wax composition contains water, at least one monohydric alcohol, at least one polyhydric alcohol, at least one nonionic emulsifier and at least one wax. The weight ratio of the nonionic emulsifier to the wax is greater than 1, so that a stickiness of the wax composition changes after application to dry or slightly wet hair.

The wax composition is applied to the dry or slightly wet hair to be shaped. Within an initial time interval immediately after application, the hair wax composition is more sticky, putting the dry or slightly wet hair to be shaped into said hairstyle.



Moisture-Regulating Cosmetic at Coty Prestige
U.S. Patent No. 7,906,158 B2; Coty Prestige Lancaster Group GmbH, Mainz, Germany, has patented a moisture-regulating cosmetic.

It is comprised of watery plant milk of the fruit of Elaeis guinensis, a watery plant milk of the leaves of Phoenix canariensis, a watery plant milk of the rice husks of Oryza sativa, a watery plant milk of the fruit of Cocos nucifera, a honey complex consisting of acacia honey, eucalyptus honey, pine honey and lavender honey, and cosmetic auxiliary substances and carrier substances.



Dermatological Composition With Avermectin Compound
U.S. Patent No. 7,897,559 B2; L. Dean Parks of Ocala, FL has patented a dermatological composition for topically treating dermatological conditions comprising transient acantholytic dermatitis, acne miliaris necrotica, acne varioliformis, perioral dermatitis, acneiform eruptions, acne vulgaris or seborrheic dermatitis.

The composition consists of an avermectin compound in a lotion consisting of glycerin, hydrogenated polyisobutene, cetearyl alcohol, polyoxyethylene ether of cetyl and stearyl alcohol, macadamia nut oil, dimethicone, tocopheryl acetate, stearoxytrimethylsilane, stearyl alcohol, panthenol, farnesol, benzyl alcohol, phenoxyethanol, acrylates/C10-30 alkyl acrylate crosspolymer, sodium hydroxide, citric acid and water.

The composition does not cause skin irritation of patients suffering from said dermatological conditions upon repetitive daily usage.